Thema
Letter
287
COVID-19 Vaccines
234
Journal Article
228
Comment
214
Editorial
124
Research Support, Non-U.S. Gov't
98
Interview
74
Antibodies, Viral
73
Antibodies, Neutralizing
61
BNT162 Vaccine
58
N38TVC63NU
58
Randomized Controlled Trial
43
Antiviral Agents
39
Multicenter Study
37
Viral Vaccines
36
2019-nCoV Vaccine mRNA-1273
35
EPK39PL4R4
35
Research Support, N.I.H., Extramural
34
Spike Glycoprotein, Coronavirus
30
3QKI37EEHE
27
415SHH325A
27
Adenosine Monophosphate
27
Alanine
27
Case Reports
27
OF5P57N2ZX
27
remdesivir
27
4QWG6N8QKH
23
Antibodies, Monoclonal
23
Hydroxychloroquine
23
Antibodies, Monoclonal, Humanized
22
B5S3K2V0G8
22
ChAdOx1 nCoV-19
22
spike protein, SARS-CoV-2
22
RNA, Messenger
21
Video-Audio Media
21
Anticoagulants
16
Comparative Study
16
Vaccines, Synthetic
15
Clinical Trial, Phase III
14
Immunoglobulin G
14
I031V2H011
12
tocilizumab
12
2494G1JF75
11
Glucocorticoids
11
Lopinavir
11
Vaccines
11
Ad26COVS1
10
JT2NS6183B
10
Receptors, Interleukin-6
10
Vaccines, Inactivated
10
mehr ...